- Clearmind Medicine (NASDAQ:CMND) Wednesday announced that it received approval for a voluntary delisting of its common shares from the Canadian Securities Exchange.
- The delisting from the CSE would not affect the company’s listing on the NASDAQ Capital Market.
- The company believes that the trading volume of its shares on the CSE no longer justifies the expenses and administrative efforts required to maintain a dual listing.
- Source: Press Release
Clearmind Medicine receives nod for delisting of shares from Canadian Securities Exchange
Date:
More like thisRelated
Tampa RV giant Lazydays to delist from Nasdaq
Tampa-based Lazydays Holdings Inc., one of Florida’s most recognized...
Granite Geek: New Hampshire might get access to ‘balcony solar’
I had solar panels put on my roof six...
TSX Today: What to Watch for in Stocks on Monday, November 10
Despite firm gold and silver prices, Canadian stocks...
While BNB and DOT Struggle Under Market Pressure, BlockDAG’s Presale Soars Past $435M!
As market-wide fear grips the sector, the Binance Coin...